Slate has an article on the use of MDMA (‘Ecstasy’) in the treatment of people with post-traumatic stress disorder or PTSD.
Limited licenses have been granted to research the use of MDMA to assist in psychotherapy, particularly for trials in people with trauma-related stress.
It will shortly be trialled to see if it can help relieve anxiety and pain in terminal cancer patients.
The Slate article looks at these recent developments, and discusses how they might be practically applied in clinical treatment plans considering some of unwanted effects that might occur.
Link to article ‘What a Long Strange Trip It’s Been’ (via Dev Intel).